Determination of heparin in blood plasma
US4202872A · kind A · utility
10Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 1, 1977 |
| Grant date | May 13, 1980 |
| Priority date | — |
| Expiry date | Mar 1, 1997 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/804
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A test for determining the anti-coagulation level in blood samples is based on ascertaining the presence of heparin-antithrombin-III complex therein. This may be done with the aid of antibodies against thrombin-antithrombin-III complex, such antibodies being used e.g. in the form of a latex reagent or a bloodcell reagent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.